| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
16 |
| Employees |
- |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
1 |
| Cash Flow (TTM) (Millions $) |
-1 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
European Biotech Acquisition Corp is a publicly traded special purpose acquisition company (SPAC) focused on acquiring businesses in the biotechnology sector in Europe. The company was formed with the intention of identifying and acquiring a target company in the biotech industry that has significant growth potential and can generate value for its shareholders. European Biotech Acquisition Corp raises funds through its initial public offering (IPO) and uses the funds to acquire a suitable biotech company. The goal of the company is to leverage its expertise and network in the European biotech sector to make strategic investments and drive innovation in the industry.
Company Address: EPFL Innovation Park Building Lausanne 1015
Company Phone Number: 77 979 21 09 Stock Exchange / Ticker: NASDAQ EBAC
|
%